SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bread Upon The Water who wrote (315)2/9/2000 1:26:00 AM
From: Dan Gibbs  Read Replies (1) of 372
 
Bill- Thanks for the info about the article recommending NZYM. It's great that the company is getting some recognition. Third quarter earnings should be released this week. I'm hoping for a pleasant surprise but am prepared for break-even to a few cents per share as forwarned by the company. I think revenues and earnings will start to pick up significantly over the next few quarters. I'm particularly excited about some of the new anti-viral protease inhibitors like the one Agouron is working on for the common cold. Some of these drugs are peptide based molecules and would need the sort of synthetic building blocks that NZYM makes. I don't know for sure which (if any) of these drugs NZYM might be involved in, but I would guess that it is a supplier for at least a couple of them. Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News